Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Merix Bioscience changes name to Argos Therapeutics, plans HIV study

Oct. 8, 2004

Another series of anti-HIV chemokine CCR5 antagonists presented by Takeda

Oct. 4, 2004

Two series of anti-HIV CCR5 antagonists reported by Takeda

Sep. 30, 2004

Lower infection rate found in some volunteers after receiving bivalent HIV vaccines

Sep. 28, 2004

Good safety profile reported for the NYVAC-HIVC vaccine in healthy volunteers

Sep. 27, 2004

GSK grants Kenyan company license for manufacture and sale of HIV/AIDS medicines in Africa

Sep. 27, 2004

Viral-specific immune responses induced with multiple-epitope vaccines for HIV-1 and SIV

Sep. 23, 2004

Last volunteers to be enrolled in phase I HIV vaccine trial

Sep. 22, 2004

New HIV medication combining two NRTIs recommended for E.U. approval

Sep. 20, 2004

Crucell and IAVI to use AdVac technology to develop AIDS vaccine

Sep. 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.